Real-world clinical and cost analysis of CT coronary angiography and CT coronary angiography-derived fractional flow reserve (FFR

To quantify the real-world clinical and cost impact of computed tomography (CT) coronary angiography (CTCA)-derived fractional flow reserve (FFRConsecutive clinical CTCA examinations from September to December 2018 with ≥1 stenosis of ≥25% underwent FFRTwo hundred and fifty-one CTCAs were performed during the study period. Fifty-seven percent (145/251) had no CAD or stenosis25%. One study was non-diagnostic. Of the remaining 42% (105/251), two were ineligible for FFRIn the real-world NHS setting, FFR